Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
11.79
+0.05 (0.46%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Dr. Reddy's Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 155,867 | - | 325,535 | 279,164 | 245,879 | 214,391 | |
Revenue Growth (YoY) | -7.82% | - | 16.61% | 13.54% | 14.69% | 13.00% |
Cost of Revenue | 84,636 | 122,392 | 135,107 | 115,557 | 106,536 | 100,551 |
Gross Profit | 71,231 | -122,392 | 190,428 | 163,607 | 139,343 | 113,840 |
Selling, General & Admin | 99,886 | 146,557 | 93,870 | 77,201 | 68,026 | 62,081 |
Depreciation & Amortization Expenses | 10,256 | 20,588 | - | - | - | - |
Research & Development | 11,229 | - | 27,380 | 22,873 | 19,381 | 17,482 |
Other Operating Expenses | -746 | 3,518 | -2,665 | -4,196 | -5,208 | 4,801 |
Total Operating Expenses | 120,625 | 170,663 | 118,585 | 95,878 | 82,199 | 84,364 |
Operating Income | 5,109 | -293,055 | 71,843 | 67,729 | 57,144 | 29,476 |
Interest Income | 10,593 | 13,584 | 7,553 | 5,705 | 4,281 | 3,077 |
Interest Expense | -461 | 3,738 | -2,829 | -1,711 | -1,428 | -958 |
Other Non-Operating Income (Expense) | 140 | 134 | 217 | 147 | 370 | 703 |
Total Non-Operating Income (Expense) | 10,272 | 17,456 | 4,941 | 4,141 | 3,223 | 2,822 |
Pretax Income | 32,880 | 53,927 | 76,784 | 71,870 | 60,367 | 32,298 |
Provision for Income Taxes | 964 | - | 19,539 | 16,186 | 15,300 | 8,730 |
Net Income | 31,916 | 41,576 | 57,245 | 55,684 | 45,067 | 23,568 |
Minority Interest in Earnings | -695 | -384 | 701 | - | - | - |
Net Income to Common | 32,206 | 41,960 | 56,544 | 55,684 | 45,067 | 23,568 |
Net Income Growth | -43.30% | -25.79% | 1.54% | 23.56% | 91.22% | 36.72% |
Shares Outstanding (Basic) | 1,224 | 832 | 833 | 832 | 830 | 829 |
Shares Outstanding (Diluted) | 1,225 | 833 | 834 | 834 | 832 | 832 |
Shares Change (YoY) | 63.03% | -0.10% | 0.08% | 0.19% | 0.03% | 0.01% |
EPS (Basic) | 26.31 | 50.41 | 67.89 | 66.93 | 54.28 | 28.42 |
EPS (Diluted) | 26.30 | 50.35 | 67.79 | 66.80 | 54.17 | 28.34 |
EPS Growth | -65.22% | -25.73% | 1.48% | 23.32% | 91.16% | 36.70% |
Free Cash Flow | 11,021 | 33,431 | 18,924 | 29,030 | 47,552 | 13,448 |
Free Cash Flow Growth | 1418.04% | 76.66% | -34.81% | -38.95% | 253.60% | -48.20% |
Free Cash Flow Per Share | 9.00 | 40.12 | 22.69 | 34.83 | 57.16 | 16.17 |
Dividends Per Share | 8.000 | 8.000 | 8.000 | 8.000 | 8.000 | 6.000 |
Dividend Growth | 0% | 0% | 0% | 0% | 33.33% | 20.00% |
Gross Margin | 45.70% | - | 58.50% | 58.61% | 56.67% | 53.10% |
Operating Margin | 3.28% | - | 22.07% | 24.26% | 23.24% | 13.75% |
Profit Margin | 20.48% | - | 17.58% | 19.95% | 18.33% | 10.99% |
FCF Margin | 7.07% | - | 5.81% | 10.40% | 19.34% | 6.27% |
EBITDA | 26,304 | -272,467 | 88,880 | 82,570 | 69,780 | 41,300 |
EBITDA Margin | 16.88% | - | 27.30% | 29.58% | 28.38% | 19.26% |
EBIT | 5,109 | -293,055 | 71,843 | 67,729 | 57,144 | 29,476 |
EBIT Margin | 3.28% | - | 22.07% | 24.26% | 23.24% | 13.75% |
Effective Tax Rate | 2.93% | 0.00% | 25.45% | 22.52% | 25.35% | 27.03% |